BRCA2 and cancer: The cumulative risk of breast cancer in carriers of variants in BRCA1 and BRCA2 genes was reported to be 72% and 69%, respectively [18], and women with BRCA1/2 variants are advised to undergo prophylactic risk-reducing surgery to decrease cancer-related mortality [19].